
Direct Co-Investment Case Study – Omega Pharma
HarbourVest’s Global Private Markets Platform Value Add
- Highly Experienced Team – HarbourVest’s large direct co-investment team, which has experience evaluating more than 300 co-investment opportunities each year, identified the need for a tax efficient structure that ensured timely co-investment execution
- Institutionalized Process – With 30-years of collective investment experience, deep skillsets, and established legal and accounting infrastructure, HarbourVest was able to work seamlessly with Waterland to evaluate, approve, and execute the deal
- Expert Local Team – HarbourVest leveraged its experienced European investment team to quickly establish trust and ensure smooth investment execution with Waterland and Omega Pharma
Benefits to HarbourVest Investors
- Co-Investment Access – HarbourVest investors gained access to a compelling co-investment deal with a world class general partner
- Manager Relationship – As a result of our long-term partnership with Waterland, HarbourVest funds invested in the general partner’s sixth fund, which was significantly oversubscribed
> View current companies
> View past co-investments